Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Aetna to CVS Health (NYSE: CVS). Under the terms of the transaction, Aetna shareholders will receive $145 in cash and 0.8378 common shares of CVS Health for each Aetna share they own. This represents an approximate value of $207 per share.
The investigation concerns whether the Board of Aetna breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether CVS Health is underpaying for Aetna shares, thus unlawfully harming Aetna shareholders.
To receive more information, please fill out the form.